Insmed Incorporated – NASDAQ:INSM

Insmed Incorporated stock price today

$127.42
+57.81
+83.05%
Financial Health
0
1
2
3
4
5
6
7
8
9

Insmed Incorporated stock price monthly change

-9.26%
month

Insmed Incorporated stock price quarterly change

-9.26%
quarter

Insmed Incorporated stock price yearly change

+120.01%
year

Insmed Incorporated key metrics

Market Cap
12.30B
Enterprise value
2.34B
P/E
-4.22
EV/Sales
9.54
EV/EBITDA
-5.21
Price/Sales
9.12
Price/Book
25.45
PEG ratio
5.45
EPS
-5.23
Revenue
315.49M
EBITDA
-671.57M
Income
-746.89M
Revenue Q/Q
15.77%
Revenue Y/Y
22.53%
Profit margin
-196.26%
Oper. margin
-191.12%
Gross margin
77.53%
EBIT margin
-191.12%
EBITDA margin
-212.87%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Insmed Incorporated stock price history

Insmed Incorporated stock forecast

Insmed Incorporated financial statements

Insmed Incorporated (NASDAQ:INSM): Profit margin
Jun 2023 77.22M -244.80M -316.99%
Sep 2023 79.07M -158.93M -201%
Dec 2023 83.69M -186.06M -222.31%
Mar 2024 75.5M -157.09M -208.07%
Insmed Incorporated (NASDAQ:INSM): Analyst Estimates
2025 516.93M -672.68M -130.13%
2026 901.46M -410.94M -45.59%
2027 1.49B 30.71M 2.06%
2028 2.12B 380.57M 17.88%
  • Analysts Price target

  • Financials & Ratios estimates

Insmed Incorporated (NASDAQ:INSM): Debt to assets
Jun 2023 1439139000 1.59B 110.82%
Sep 2023 1324873000 1.61B 121.84%
Dec 2023 1329837000 1.66B 124.96%
Mar 2024 1159095000 1.62B 140.1%
Insmed Incorporated (NASDAQ:INSM): Cash Flow
Jun 2023 -122.79M -274.15M 44.32M
Sep 2023 -136.33M 7.14M 1.24M
Dec 2023 -130.81M 1.80M 123.26M
Mar 2024 -184.03M 295.32M 3.02M

Insmed Incorporated alternative data

Insmed Incorporated (NASDAQ:INSM): Employee count
Sep 2023 736
Oct 2023 736
Nov 2023 736
Dec 2023 736
Jan 2024 736
Feb 2024 736
Mar 2024 912
Apr 2024 912
May 2024 912
Jun 2024 912
Jul 2024 912

Insmed Incorporated other data

100.00% 0.00%
of INSM is owned by hedge funds
125.14M +2.01M
shares is hold by hedge funds

Insmed Incorporated (NASDAQ:INSM): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 125386
May 2024 0 525422
Jun 2024 0 76195
Aug 2024 0 97539
Sep 2024 0 254853
Dec 2024 0 51160
Transaction Date Insider Security Shares Price per share Total value Source
Option
LEWIS WILLIAM director, officer.. Common Stock 18,750 $22.76 $426,750
Sale
LEWIS WILLIAM director, officer.. Common Stock 13,162 $69.65 $916,733
Sale
LEWIS WILLIAM director, officer.. Common Stock 5,588 $70.52 $394,066
Option
LEWIS WILLIAM director, officer.. Common Stock 6,830 $10.85 $74,106
Sale
LEWIS WILLIAM director, officer.. Common Stock 5,240 $69.71 $365,280
Sale
LEWIS WILLIAM director, officer.. Common Stock 1,590 $70.61 $112,270
Option
LEWIS WILLIAM director, officer.. Stock Option (right to buy) 6,830 $10.85 $74,106
Option
LEWIS WILLIAM director, officer.. Stock Option (right to buy) 18,750 $22.76 $426,750
Option
LEWIS WILLIAM director, officer.. Common Stock 18,750 $22.76 $426,750
Sale
LEWIS WILLIAM director, officer.. Common Stock 11,504 $72.58 $834,960
Patent
Application
Filling date: 10 Jun 2021 Issue date: 5 May 2022
Application
Filling date: 10 Mar 2021 Issue date: 20 Jan 2022
Application
Filling date: 12 Feb 2021 Issue date: 2 Dec 2021
Application
Filling date: 16 Jul 2019 Issue date: 21 Oct 2021
Insider Compensation
Mr. William H. Lewis J.D., M.B.A. (1969) Pres, Chief Executive Officer & Chairman $1,190,000
Dr. Martina Flammer M.B.A., M.D. (1964) Chief Medical Officer
$934,410
Mr. Roger Adsett (1969) Chief Operating Officer $793,900
Ms. Christine A. Pellizzari J.D. (1968) Consultant $732,850
Ms. Sara M. Bonstein MBA (1981) Chief Financial Officer
$697,720
Monday, 23 December 2024
zacks.com
Friday, 6 December 2024
prnewswire.com
Monday, 2 December 2024
prnewswire.com
Wednesday, 20 November 2024
seekingalpha.com
Thursday, 7 November 2024
prnewswire.com
Wednesday, 6 November 2024
prnewswire.com
Monday, 4 November 2024
zacks.com
Friday, 1 November 2024
zacks.com
Thursday, 31 October 2024
seekingalpha.com
zacks.com
zacks.com
prnewswire.com
Wednesday, 30 October 2024
zacks.com
Thursday, 24 October 2024
prnewswire.com
Wednesday, 23 October 2024
prnewswire.com
Thursday, 17 October 2024
zacks.com
prnewswire.com
Tuesday, 8 October 2024
prnewswire.com
Friday, 4 October 2024
prnewswire.com
Tuesday, 10 September 2024
schaeffersresearch.com
Friday, 6 September 2024
prnewswire.com
Wednesday, 28 August 2024
seekingalpha.com
Tuesday, 27 August 2024
zacks.com
Saturday, 24 August 2024
investors.com
Friday, 9 August 2024
seekingalpha.com
zacks.com
Thursday, 8 August 2024
zacks.com
zacks.com
prnewswire.com
Friday, 2 August 2024
prnewswire.com
  • What's the price of Insmed Incorporated stock today?

    One share of Insmed Incorporated stock can currently be purchased for approximately $127.42.

  • When is Insmed Incorporated's next earnings date?

    Unfortunately, Insmed Incorporated's (INSM) next earnings date is currently unknown.

  • Does Insmed Incorporated pay dividends?

    No, Insmed Incorporated does not pay dividends.

  • How much money does Insmed Incorporated make?

    Insmed Incorporated has a market capitalization of 12.30B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.39% to 305.21M US dollars.

  • What is Insmed Incorporated's stock symbol?

    Insmed Incorporated is traded on the NASDAQ under the ticker symbol "INSM".

  • What is Insmed Incorporated's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Insmed Incorporated?

    Shares of Insmed Incorporated can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Insmed Incorporated's key executives?

    Insmed Incorporated's management team includes the following people:

    • Mr. William H. Lewis J.D., M.B.A. Pres, Chief Executive Officer & Chairman(age: 56, pay: $1,190,000)
    • Dr. Martina Flammer M.B.A., M.D. Chief Medical Officer(age: 61, pay: $934,410)
    • Mr. Roger Adsett Chief Operating Officer(age: 56, pay: $793,900)
    • Ms. Christine A. Pellizzari J.D. Consultant(age: 57, pay: $732,850)
    • Ms. Sara M. Bonstein MBA Chief Financial Officer(age: 44, pay: $697,720)
  • How many employees does Insmed Incorporated have?

    As Jul 2024, Insmed Incorporated employs 912 workers.

  • When Insmed Incorporated went public?

    Insmed Incorporated is publicly traded company for more then 25 years since IPO on 1 Jun 2000.

  • What is Insmed Incorporated's official website?

    The official website for Insmed Incorporated is insmed.com.

  • Where are Insmed Incorporated's headquarters?

    Insmed Incorporated is headquartered at 700 US Highway 202/206, Bridgewater, NJ.

  • How can i contact Insmed Incorporated?

    Insmed Incorporated's mailing address is 700 US Highway 202/206, Bridgewater, NJ and company can be reached via phone at +90 89779900.

Insmed Incorporated company profile:

Insmed Incorporated

insmed.com
Exchange:

NASDAQ

Full time employees:

912

Industry:

Biotechnology

Sector:

Healthcare

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

700 US Highway 202/206
Bridgewater, NJ 08807

CIK: 0001104506
ISIN: US4576693075
CUSIP: 457669307